Compounds for the Treatment of Metabolic Disorders
申请人:Barba Oscar
公开号:US20120059014A1
公开(公告)日:2012-03-08
The present invention is directed to therapeutic compounds of the following formula (I)
which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.
The invention provides compounds of formula (1),
and the pharmaceutically acceptable salt thereof, wherein R1, n and R2 are as described herein; compositions thereof; and uses thereof.